Condition: Immunotherapy With Pembrolizumab for Nasopharyngeal Carcinoma Patients
Intervention: Drug: Pembrolizumab
Sponsors: National Health Research Institutes, Taiwan; National Taiwan University Hospital; Koo Foundation Sun Yat-Sen Cancer Center; Chang Gung Memorial Hospital; Taichung Veterans General Hospital; China Medical University Hospital; Changhua Christian Hospital; National Cheng-Kung University Hospital
Not yet recruiting
https://ift.tt/2IZ4YMK
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Summary Insulinomas are rare neuroendocrine tumours that classically present with fasting hypoglycaemia. This case report discusses an un...
-
The online platform for Taylor & Francis Online content New for Canadian Journal of Remote Sen...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου